Findings from a phase I study of concurrent ipilimumab and nivolumab for advanced melanoma
Older individuals with nonmelanoma skin cancer seem to have a significantly reduced risk of developing Alzheimer's disease, according to a Neurology study.
Genetech announced results from CLL11, a Phase 3 study of obinutuzumab (GA101), comparing the combination of either obinutuzumab or Rituxan and chlorambucil to chlorambucil alone in chronic lymphocytic leukemia (CLL).
Gilead announced Phase 2 results for idelalisib, an oral inhibitor of PI3K delta in combination with rituximab for older patients with treatment-naïve chronic lymphocytic leukemia.
Findings show younger cancer patients are increasingly vulnerable to bankruptcy.
Research shows discrepancies in the way the role of nurse practitioners is viewed.
The FDA has approved Xofigo (radium Ra 223 dichloride; Bayer) for the treatment of symptomatic late-stage castration-resistant prostate cancer with bone metastases.
The cobas EGFR Mutation Test, a companion diagnostic for Tarceva, has been approved by the FDA to detect lung-cancer-related gene mutation.
Significant associations seen in men's urinary and sexual function based on surgeon performing radical prostatectomy.
Review shows significant reductions in anxiety, depression, pain; improved QoL during treatment
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|